OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGFβ1-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma
Jing Quan, Can Cheng, Yue Tan, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2484-2496
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
Yufei Yang, Ting Zhu, Xu Wang, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5896-5896
Open Access | Times Cited: 103

Lipids as mediators of cancer progression and metastasis
Felix C. E. Vogel, Adriano B. Chaves‐Filho, Almut Schulze
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 16-29
Closed Access | Times Cited: 50

The emerging roles of HDACs and their therapeutic implications in cancer
Rihan Hai, Deyi Yang, Feifei Zheng, et al.
European Journal of Pharmacology (2022) Vol. 931, pp. 175216-175216
Closed Access | Times Cited: 50

TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development
Xiao-Shuang Li, Yanmin Wu, Tian Tian
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14436-14436
Open Access | Times Cited: 46

circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
Yufei Yang, Dakui Luo, Yang Shao, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 100-122
Open Access | Times Cited: 39

Targeting fatty acid oxidation: A potential strategy for treating gastrointestinal tumors
Yaxi Zheng, Zhengchen Jiang, Li Yuan, et al.
International Journal of Cancer (2025)
Closed Access | Times Cited: 1

Colorectal Cancer: Pathogenesis and Targeted Therapy
Jingyuan Li, Jiashu Pan, Lisheng Wang, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1

Colorectal cancer: Metabolic interactions reshape the tumor microenvironment
Jiawei Chen, Haodong Zhu, Yuhang Yin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188797-188797
Closed Access | Times Cited: 35

Disulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications
Qiuyang Gu, Yumei An, Mingyuan Xu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 7

Targeting ACSLs to modulate ferroptosis and cancer immunity
Junhong Lin, Yongfeng Lai, Fujia Lu, et al.
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 6

Lipid metabolism reprogramming in colorectal cancer
Dan Chen, Xuebing Zhou, PengYu Yan, et al.
Journal of Cellular Biochemistry (2022) Vol. 124, Iss. 1, pp. 3-16
Closed Access | Times Cited: 22

G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells
Athena Kyrkou, Robert Valla, Yao Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

LPCAT2-mediated lipid droplet production supports pancreatic cancer chemoresistance and cell motility
Yuhe Lin, Xin Zhang, Yihui Wang, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112681-112681
Closed Access | Times Cited: 4

Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy
Siyuan Jia, Ann M. Bode, Xue Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189166-189166
Closed Access | Times Cited: 4

Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications
Xiangyu Wang, Yinuo Li, Xin Hou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism
Zhenzhen Li, Yue Tan, Xiang Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 19

The role of circadian clocks in cancer: Mechanisms and clinical implications
Huiwen Liu, Ying Liu, Rihan Hai, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1279-1290
Open Access | Times Cited: 17

Lipid metabolic vulnerabilities of multiple myeloma
Roberta Torcasio, Maria Eugenia Gallo Cantafio, Raissa Kaori Ikeda, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3373-3390
Open Access | Times Cited: 10

Isolation and Characterization of the Adamantinomatous Craniopharyngioma Primary Cells with Cancer-Associated Fibroblast Features
Dongting Chen, Ting Lei, Yu‐Lin Wang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 912-912
Open Access

Lipid Droplet - Organelle Crosstalk and its Implication in Cancer
Jing Quan, Chunhong Zhang, Xue Chen, et al.
Progress in Biophysics and Molecular Biology (2025)
Closed Access

Oxidative complexity: The role of ROS in the tumor environment and therapeutic implications
Ting Shen, Yutong Wang, Likun Cheng, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 127, pp. 118241-118241
Closed Access

Page 1 - Next Page

Scroll to top